Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-06

Clinical Trial Update: Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessed the effect of dapagliflozin on hepatic and renal glucose metabolism in adults with type 2 diabetes; results have been posted a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2023-06-06